25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Resmed Inc DRC
Buy, Hold or Sell?

Let's analyze Resmed together

I guess you are interested in Resmed Inc DRC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Resmed Inc DRC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Resmed Inc DRC

I send you an email if I find something interesting about Resmed Inc DRC.

1. Quick Overview

1.1. Quick analysis of Resmed (30 sec.)










1.2. What can you expect buying and holding a share of Resmed? (30 sec.)

How much money do you get?

How much money do you get?
€0.19
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€3.31
Expected worth in 1 year
€3.81
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
€0.67
Return On Investment
3.1%

For what price can you sell your share?

Current Price per Share
€21.40
Expected price per share
€20.88 - €22.80
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Resmed (5 min.)




Live pricePrice per Share (EOD)
€21.40
Intrinsic Value Per Share
€9.31 - €11.04
Total Value Per Share
€12.62 - €14.35

2.2. Growth of Resmed (5 min.)




Is Resmed growing?

Current yearPrevious yearGrowGrow %
How rich?$5.4b$4.2b$835.4m16.4%

How much money is Resmed making?

Current yearPrevious yearGrowGrow %
Making money$284.9m$250.5m$34.4m12.1%
Net Profit Margin21.7%21.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Resmed (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#11 / 170

Most Revenue
#18 / 170

Most Profit
#11 / 170
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Resmed?

Welcome investor! Resmed's management wants to use your money to grow the business. In return you get a share of Resmed.

First you should know what it really means to hold a share of Resmed. And how you can make/lose money.

Speculation

The Price per Share of Resmed is €21.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Resmed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Resmed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €3.31. Based on the TTM, the Book Value Change Per Share is €0.12 per quarter. Based on the YOY, the Book Value Change Per Share is €0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Resmed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.221.0%0.190.9%0.170.8%0.140.7%0.140.7%
Usd Book Value Change Per Share0.180.8%0.140.7%0.150.7%0.180.9%0.180.9%
Usd Dividend Per Share0.050.2%0.050.2%0.040.2%0.040.2%0.040.2%
Usd Total Gains Per Share0.231.1%0.190.9%0.190.9%0.231.1%0.231.1%
Usd Price Per Share19.88-18.26-22.53-19.94-19.94-
Price to Earnings Ratio22.37-23.84-33.23-27.67-27.67-
Price-to-Total Gains Ratio87.97-100.86-138.75-120.50-120.50-
Price to Book Ratio5.38-5.26-7.84-8.21-8.21-
Price-to-Total Gains Ratio87.97-100.86-138.75-120.50-120.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share23.89524
Number of shares41
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.04
Usd Book Value Change Per Share0.140.18
Usd Total Gains Per Share0.190.23
Gains per Quarter (41 shares)7.699.30
Gains per Year (41 shares)30.7537.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18232173027
2164652146164
32469832191101
4329111428121138
53911414535152175
64713717641182212
75516020748212249
86318323855242286
97120626962273323
107922930069303360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%19.01.00.095.0%19.01.00.095.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%18.02.00.090.0%18.02.00.090.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%19.01.00.095.0%19.01.00.095.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Resmed Inc DRC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1590.125+28%0.131+22%0.166-4%0.166-4%
Book Value Per Share--3.3103.101+7%2.592+28%2.264+46%2.264+46%
Current Ratio--2.5892.933-12%3.075-16%2.642-2%2.642-2%
Debt To Asset Ratio--0.2920.333-12%0.395-26%0.390-25%0.390-25%
Debt To Equity Ratio--0.4130.503-18%0.659-37%0.655-37%0.655-37%
Dividend Per Share--0.0430.0430%0.039+9%0.038+14%0.038+14%
Eps--0.1990.174+14%0.152+31%0.129+54%0.129+54%
Free Cash Flow Per Share--0.2520.196+29%0.085+196%0.108+134%0.108+134%
Free Cash Flow To Equity Per Share--0.0130.025-51%0.164-92%0.049-75%0.049-75%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--11.038--------
Intrinsic Value_10Y_min--9.312--------
Intrinsic Value_1Y_max--0.515--------
Intrinsic Value_1Y_min--0.506--------
Intrinsic Value_3Y_max--1.999--------
Intrinsic Value_3Y_min--1.899--------
Intrinsic Value_5Y_max--4.025--------
Intrinsic Value_5Y_min--3.697--------
Market Cap31443446630.400+17%26153894860.80024023380953.600+9%29643529708.800-12%26234707457.2800%26234707457.2800%
Net Profit Margin--0.2390.217+10%0.213+12%0.201+19%0.201+19%
Operating Margin----0%0.206-100%0.216-100%0.216-100%
Operating Ratio--1.1031.139-3%1.168-6%1.148-4%1.148-4%
Pb Ratio6.464+17%5.3775.263+2%7.843-31%8.208-34%8.208-34%
Pe Ratio26.899+17%22.37423.835-6%33.234-33%27.666-19%27.666-19%
Price Per Share21.400+17%17.80016.350+9%20.175-12%17.8550%17.8550%
Price To Free Cash Flow Ratio21.212+17%17.64321.604-18%222.241-92%73.628-76%73.628-76%
Price To Total Gains Ratio105.760+17%87.968100.861-13%138.750-37%120.497-27%120.497-27%
Quick Ratio--0.9190.945-3%0.946-3%0.894+3%0.894+3%
Return On Assets--0.0430.037+14%0.036+19%0.035+22%0.035+22%
Return On Equity--0.0600.056+8%0.059+2%0.057+5%0.057+5%
Total Gains Per Share--0.2020.168+20%0.170+19%0.2030%0.2030%
Usd Book Value--5431190413.8005087841775.950+7%4252410867.900+28%3714851712.900+46%3714851712.900+46%
Usd Book Value Change Per Share--0.1780.139+28%0.146+22%0.185-4%0.185-4%
Usd Book Value Per Share--3.6963.463+7%2.894+28%2.528+46%2.528+46%
Usd Dividend Per Share--0.0480.0480%0.044+9%0.042+14%0.042+14%
Usd Eps--0.2220.194+14%0.170+31%0.144+54%0.144+54%
Usd Free Cash Flow--413802155.805321609670.363+29%139828519.675+196%158872783.095+160%158872783.095+160%
Usd Free Cash Flow Per Share--0.2820.219+29%0.095+196%0.120+134%0.120+134%
Usd Free Cash Flow To Equity Per Share--0.0140.028-51%0.183-92%0.055-75%0.055-75%
Usd Market Cap35109752507.505+17%29203439001.56926824507172.790+9%33099965272.846-12%29293674346.7990%29293674346.7990%
Usd Price Per Share23.895+17%19.87518.256+9%22.527-12%19.9370%19.9370%
Usd Profit--326310717.600284998192.500+14%250552757.400+30%211825719.600+54%211825719.600+54%
Usd Revenue--1365819537.0001307900657.550+4%1178848495.950+16%1040685324.990+31%1040685324.990+31%
Usd Total Gains Per Share--0.2260.188+20%0.190+19%0.2270%0.2270%
 EOD+4 -4MRQTTM+25 -9YOY+26 -95Y+23 -1210Y+23 -12

3.3 Fundamental Score

Let's check the fundamental score of Resmed Inc DRC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1526.899
Price to Book Ratio (EOD)Between0-16.464
Net Profit Margin (MRQ)Greater than00.239
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.919
Current Ratio (MRQ)Greater than12.589
Debt to Asset Ratio (MRQ)Less than10.292
Debt to Equity Ratio (MRQ)Less than10.413
Return on Equity (MRQ)Greater than0.150.060
Return on Assets (MRQ)Greater than0.050.043
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Resmed Inc DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.564
Ma 20Greater thanMa 5021.730
Ma 50Greater thanMa 10020.005
Ma 100Greater thanMa 20019.182
OpenGreater thanClose21.400
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Resmed Inc DRC

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-09-18 21:52:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Resmed earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 23.9% means that €0.24 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Resmed Inc DRC:

  • The MRQ is 23.9%. The company is making a huge profit. +2
  • The TTM is 21.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.9%TTM21.7%+2.2%
TTM21.7%YOY21.3%+0.4%
TTM21.7%5Y20.1%+1.7%
5Y20.1%10Y20.1%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ23.9%6.5%+17.4%
TTM21.7%5.7%+16.0%
YOY21.3%6.2%+15.1%
5Y20.1%6.8%+13.3%
10Y20.1%7.7%+12.4%
4.3.1.2. Return on Assets

Shows how efficient Resmed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • 4.3% Return on Assets means that Resmed generated €0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Resmed Inc DRC:

  • The MRQ is 4.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.3%TTM3.7%+0.5%
TTM3.7%YOY3.6%+0.2%
TTM3.7%5Y3.5%+0.3%
5Y3.5%10Y3.5%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3%0.9%+3.4%
TTM3.7%0.9%+2.8%
YOY3.6%1.4%+2.2%
5Y3.5%1.6%+1.9%
10Y3.5%1.6%+1.9%
4.3.1.3. Return on Equity

Shows how efficient Resmed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • 6.0% Return on Equity means Resmed generated €0.06 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Resmed Inc DRC:

  • The MRQ is 6.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.0%TTM5.6%+0.4%
TTM5.6%YOY5.9%-0.3%
TTM5.6%5Y5.7%-0.1%
5Y5.7%10Y5.7%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0%1.6%+4.4%
TTM5.6%1.5%+4.1%
YOY5.9%2.7%+3.2%
5Y5.7%3.2%+2.5%
10Y5.7%3.1%+2.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Resmed Inc DRC.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Resmed is operating .

  • Measures how much profit Resmed makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Resmed Inc DRC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY20.6%-20.6%
TTM-5Y21.6%-21.6%
5Y21.6%10Y21.6%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.7%-6.7%
TTM-3.8%-3.8%
YOY20.6%9.7%+10.9%
5Y21.6%9.7%+11.9%
10Y21.6%9.5%+12.1%
4.3.2.2. Operating Ratio

Measures how efficient Resmed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.10 means that the operating costs are €1.10 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Resmed Inc DRC:

  • The MRQ is 1.103. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.139. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.103TTM1.139-0.036
TTM1.139YOY1.168-0.029
TTM1.1395Y1.148-0.009
5Y1.14810Y1.1480.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1031.118-0.015
TTM1.1391.180-0.041
YOY1.1681.114+0.054
5Y1.1481.066+0.082
10Y1.1481.037+0.111
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Resmed Inc DRC.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Resmed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.59 means the company has €2.59 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Resmed Inc DRC:

  • The MRQ is 2.589. The company is able to pay all its short-term debts. +1
  • The TTM is 2.933. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.589TTM2.933-0.344
TTM2.933YOY3.075-0.142
TTM2.9335Y2.642+0.291
5Y2.64210Y2.6420.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5892.114+0.475
TTM2.9332.312+0.621
YOY3.0752.506+0.569
5Y2.6422.649-0.007
10Y2.6422.637+0.005
4.4.3.2. Quick Ratio

Measures if Resmed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.92 means the company can pay off €0.92 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Resmed Inc DRC:

  • The MRQ is 0.919. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.945. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.919TTM0.945-0.026
TTM0.945YOY0.946-0.001
TTM0.9455Y0.894+0.051
5Y0.89410Y0.8940.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9190.932-0.013
TTM0.9450.996-0.051
YOY0.9461.158-0.212
5Y0.8941.355-0.461
10Y0.8941.541-0.647
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Resmed Inc DRC.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Resmed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Resmed to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.29 means that Resmed assets are financed with 29.2% credit (debt) and the remaining percentage (100% - 29.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Resmed Inc DRC:

  • The MRQ is 0.292. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.333. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.292TTM0.333-0.041
TTM0.333YOY0.395-0.062
TTM0.3335Y0.390-0.057
5Y0.39010Y0.3900.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2920.366-0.074
TTM0.3330.359-0.026
YOY0.3950.349+0.046
5Y0.3900.362+0.028
10Y0.3900.371+0.019
4.5.4.2. Debt to Equity Ratio

Measures if Resmed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 41.3% means that company has €0.41 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Resmed Inc DRC:

  • The MRQ is 0.413. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.503. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.413TTM0.503-0.090
TTM0.503YOY0.659-0.156
TTM0.5035Y0.655-0.152
5Y0.65510Y0.6550.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4130.560-0.147
TTM0.5030.562-0.059
YOY0.6590.534+0.125
5Y0.6550.599+0.056
10Y0.6550.662-0.007
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Resmed generates.

  • Above 15 is considered overpriced but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 22.37 means the investor is paying €22.37 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Resmed Inc DRC:

  • The EOD is 26.899. Based on the earnings, the company is overpriced. -1
  • The MRQ is 22.374. Based on the earnings, the company is fair priced.
  • The TTM is 23.835. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD26.899MRQ22.374+4.525
MRQ22.374TTM23.835-1.461
TTM23.835YOY33.234-9.399
TTM23.8355Y27.666-3.831
5Y27.66610Y27.6660.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD26.89915.861+11.038
MRQ22.37416.592+5.782
TTM23.83516.646+7.189
YOY33.23419.321+13.913
5Y27.66620.963+6.703
10Y27.66625.820+1.846
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Resmed Inc DRC:

  • The EOD is 21.212. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 17.643. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 21.604. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD21.212MRQ17.643+3.568
MRQ17.643TTM21.604-3.960
TTM21.604YOY222.241-200.637
TTM21.6045Y73.628-52.024
5Y73.62810Y73.6280.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD21.2128.763+12.449
MRQ17.6438.443+9.200
TTM21.6048.882+12.722
YOY222.241-0.155+222.396
5Y73.6284.568+69.060
10Y73.6281.956+71.672
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Resmed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 5.38 means the investor is paying €5.38 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Resmed Inc DRC:

  • The EOD is 6.464. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.377. Based on the equity, the company is overpriced. -1
  • The TTM is 5.263. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.464MRQ5.377+1.087
MRQ5.377TTM5.263+0.114
TTM5.263YOY7.843-2.581
TTM5.2635Y8.208-2.945
5Y8.20810Y8.2080.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD6.4642.439+4.025
MRQ5.3772.414+2.963
TTM5.2632.617+2.646
YOY7.8432.876+4.967
5Y8.2083.972+4.236
10Y8.2084.396+3.812
4.6.2. Total Gains per Share

2.4. Latest News of Resmed Inc DRC

Does Resmed Inc DRC still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Resmed Inc DRC to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2024-09-16
15:45
Why This 1 Growth Stock Could Be a Great Addition to Your PortfolioRead
2024-09-13
15:50
Are You a Momentum Investor? This 1 Stock Could Be the Perfect PickRead
2024-09-11
07:24
Insider Sale: CFO Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD)Read
2024-09-10
22:05
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock ExchangeRead
2024-09-06
23:00
Insider Sale: Director Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD)Read
2024-09-02
13:00
Is There An Opportunity With ResMed Inc.'s (NYSE:RMD) 28% Undervaluation?Read
2024-08-30
15:45
Here's Why ResMed (RMD) is a Strong Growth StockRead
2024-08-28
22:05
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare ConferenceRead
2024-08-26
15:50
Why This 1 Momentum Stock Could Be a Great Addition to Your PortfolioRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets6,872,394
Total Liabilities2,008,351
Total Stockholder Equity4,864,043
 As reported
Total Liabilities 2,008,351
Total Stockholder Equity+ 4,864,043
Total Assets = 6,872,394

Assets

Total Assets6,872,394
Total Current Assets2,357,719
Long-term Assets4,514,675
Total Current Assets
Cash And Cash Equivalents 238,361
Net Receivables 837,275
Inventory 822,250
Other Current Assets 180,012
Total Current Assets  (as reported)2,357,719
Total Current Assets  (calculated)2,077,898
+/- 279,821
Long-term Assets
Property Plant Equipment 699,146
Goodwill 2,842,055
Intangible Assets 485,904
Long-term Assets Other 284,001
Long-term Assets  (as reported)4,514,675
Long-term Assets  (calculated)4,311,106
+/- 203,569

Liabilities & Shareholders' Equity

Total Current Liabilities910,655
Long-term Liabilities1,097,696
Total Stockholder Equity4,864,043
Total Current Liabilities
Short Long Term Debt 9,900
Accounts payable 237,728
Other Current Liabilities 4,654
Total Current Liabilities  (as reported)910,655
Total Current Liabilities  (calculated)252,282
+/- 658,373
Long-term Liabilities
Long term Debt 697,313
Capital Lease Obligations Min Short Term Debt166,722
Long-term Liabilities Other 42,257
Long-term Liabilities  (as reported)1,097,696
Long-term Liabilities  (calculated)906,292
+/- 191,404
Total Stockholder Equity
Retained Earnings 4,991,647
Total Stockholder Equity (as reported)4,864,043
Total Stockholder Equity (calculated)4,991,647
+/- 127,604
Other
Capital Stock588
Common Stock Shares Outstanding 146,901
Net Debt 468,852
Net Invested Capital 5,571,256
Net Working Capital 1,447,064
Property Plant and Equipment Gross 1,426,113



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
4,154,558
4,353,939
4,510,543
4,587,376
4,620,844
4,572,856
4,585,724
4,728,125
4,729,167
4,734,742
4,905,264
5,095,853
5,177,560
6,676,104
6,713,879
6,751,708
6,740,786
6,905,088
6,814,562
6,872,394
6,872,3946,814,5626,905,0886,740,7866,751,7086,713,8796,676,1045,177,5605,095,8534,905,2644,734,7424,729,1674,728,1254,585,7244,572,8564,620,8444,587,3764,510,5434,353,9394,154,558
   > Total Current Assets 
1,161,098
1,300,485
1,469,758
1,523,459
1,542,609
1,451,485
1,466,150
1,574,757
1,586,255
1,547,240
1,704,300
1,931,478
2,033,697
2,325,156
2,337,815
2,367,830
2,304,585
2,378,077
2,351,296
2,357,719
2,357,7192,351,2962,378,0772,304,5852,367,8302,337,8152,325,1562,033,6971,931,4781,704,3001,547,2401,586,2551,574,7571,466,1501,451,4851,542,6091,523,4591,469,7581,300,4851,161,098
       Cash And Cash Equivalents 
172,154
204,095
352,861
463,156
421,414
255,865
230,635
295,278
276,149
194,476
201,769
273,710
207,163
253,199
227,894
227,891
209,100
210,247
237,910
238,361
238,361237,910210,247209,100227,891227,894253,199207,163273,710201,769194,476276,149295,278230,635255,865421,414463,156352,861204,095172,154
       Net Receivables 
493,836
535,831
563,404
484,095
474,478
518,817
537,554
625,185
601,353
550,719
534,233
601,642
644,098
695,381
712,168
736,430
692,388
729,740
779,265
837,275
837,275779,265729,740692,388736,430712,168695,381644,098601,642534,233550,719601,353625,185537,554518,817474,478484,095563,404535,831493,836
       Inventory 
357,033
377,784
358,772
416,915
478,006
474,821
484,061
457,033
506,644
592,146
664,943
743,910
987,691
1,138,817
1,150,385
1,141,096
958,233
933,214
829,458
822,250
822,250829,458933,214958,2331,141,0961,150,3851,138,817987,691743,910664,943592,146506,644457,033484,061474,821478,006416,915358,772377,784357,033
   > Long-term Assets 
2,993,460
3,053,454
3,040,785
3,063,917
3,078,235
3,121,371
3,119,574
3,153,368
3,142,912
3,187,502
3,200,964
3,164,375
3,143,863
4,350,948
4,376,064
4,383,878
4,436,201
4,527,011
4,463,266
4,514,675
4,514,6754,463,2664,527,0114,436,2014,383,8784,376,0644,350,9483,143,8633,164,3753,200,9643,187,5023,142,9123,153,3683,119,5743,121,3713,078,2353,063,9173,040,7853,053,4542,993,460
       Property Plant Equipment 
0
505,109
523,486
535,683
549,292
590,763
583,861
592,065
601,719
623,823
654,423
630,495
612,695
650,967
656,286
665,811
657,401
705,207
686,818
699,146
699,146686,818705,207657,401665,811656,286650,967612,695630,495654,423623,823601,719592,065583,861590,763549,292535,683523,486505,1090
       Goodwill 
1,856,427
1,870,647
1,884,458
1,890,324
1,899,743
1,910,492
1,925,991
1,927,901
1,922,037
1,951,459
1,946,317
1,936,442
1,938,843
2,767,179
2,783,624
2,770,299
2,812,142
2,861,854
2,835,993
2,842,055
2,842,0552,835,9932,861,8542,812,1422,770,2992,783,6242,767,1791,938,8431,936,4421,946,3171,951,4591,922,0371,927,9011,925,9911,910,4921,899,7431,890,3241,884,4581,870,6471,856,427
       Intangible Assets 
496,847
480,861
464,963
448,168
432,894
412,998
409,559
392,582
375,400
372,013
355,984
345,944
338,151
586,857
569,678
552,341
563,278
528,178
501,024
485,904
485,904501,024528,178563,278552,341569,678586,857338,151345,944355,984372,013375,400392,582409,559412,998432,894448,168464,963480,861496,847
       Other Assets 
0
142,098
117,760
145,600
156,825
164,027
160,447
200,664
196,828
191,173
193,583
202,286
223,282
216,149
228,139
261,313
0
0
0
0
0000261,313228,139216,149223,282202,286193,583191,173196,828200,664160,447164,027156,825145,600117,760142,0980
> Total Liabilities 
2,037,307
2,095,833
2,254,112
2,090,349
1,941,984
1,707,872
1,876,490
1,842,446
1,703,118
1,588,907
1,626,460
1,735,102
1,744,673
2,937,977
2,781,370
2,621,805
2,490,410
2,423,234
2,184,642
2,008,351
2,008,3512,184,6422,423,2342,490,4102,621,8052,781,3702,937,9771,744,6731,735,1021,626,4601,588,9071,703,1181,842,4461,876,4901,707,8721,941,9842,090,3492,254,1122,095,8332,037,307
   > Total Current Liabilities 
550,457
500,045
551,519
602,761
590,853
577,335
876,541
911,766
624,158
621,064
667,265
689,299
692,659
732,714
761,691
758,533
770,802
764,073
773,030
910,655
910,655773,030764,073770,802758,533761,691732,714692,659689,299667,265621,064624,158911,766876,541577,335590,853602,761551,519500,045550,457
       Short Long Term Debt 
11,992
11,984
11,987
11,987
11,988
11,988
11,990
12,000
12,000
12,000
11,967
9,916
9,906
9,900
9,901
9,902
9,905
9,898
9,903
9,900
9,9009,9039,8989,9059,9029,9019,9009,9069,91611,96712,00012,00012,00011,99011,98811,98811,98711,98711,98411,992
       Accounts payable 
109,742
114,322
116,148
135,786
117,589
122,166
117,222
138,008
173,696
163,369
149,797
159,245
181,485
196,003
161,896
150,756
177,048
202,395
177,445
237,728
237,728177,445202,395177,048150,756161,896196,003181,485159,245149,797163,369173,696138,008117,222122,166117,589135,786116,148114,322109,742
       Other Current Liabilities 
0
159,981
189,386
195,078
201,079
175,173
451,003
447,769
172,497
165,560
185,532
179,449
181,430
221,081
250,858
247,475
0
0
0
4,654
4,654000247,475250,858221,081181,430179,449185,532165,560172,497447,769451,003175,173201,079195,078189,386159,9810
   > Long-term Liabilities 
1,486,850
1,595,788
1,702,593
1,487,588
1,351,131
1,130,537
999,949
930,680
1,078,960
967,843
959,195
1,045,803
1,052,014
2,205,263
2,019,679
1,863,272
1,719,608
1,659,161
1,411,612
1,097,696
1,097,6961,411,6121,659,1611,719,6081,863,2722,019,6792,205,2631,052,0141,045,803959,195967,8431,078,960930,680999,9491,130,5371,351,1311,487,5881,702,5931,595,7881,486,850
       Long term Debt 
1,208,210
1,287,509
1,364,849
1,164,133
1,044,435
813,732
719,046
643,351
793,668
667,979
668,735
765,325
785,436
1,790,689
1,575,963
1,431,234
1,351,511
1,216,769
997,047
697,313
697,313997,0471,216,7691,351,5111,431,2341,575,9631,790,689785,436765,325668,735667,979793,668643,351719,046813,7321,044,4351,164,1331,364,8491,287,5091,208,210
       Capital Lease Obligations Min Short Term Debt
85,386
99,496
130,046
123,143
132,512
140,086
137,765
138,364
144,437
156,882
151,384
142,309
135,290
138,874
138,219
138,772
134,243
164,706
160,495
166,722
166,722160,495164,706134,243138,772138,219138,874135,290142,309151,384156,882144,437138,364137,765140,086132,512123,143130,04699,49685,386
       Other Liabilities 
0
228,821
230,493
221,575
195,513
199,164
165,637
172,550
163,774
166,894
163,206
160,025
152,364
298,129
0
315,185
0
0
0
0
0000315,1850298,129152,364160,025163,206166,894163,774172,550165,637199,164195,513221,575230,493228,8210
       Long-term Liabilities Other 
2,047
2,062
7,527
8,347
8,568
9,481
6,067
6,802
5,981
6,350
5,103
5,974
5,838
50,603
69,553
68,166
34,328
72,894
47,550
42,257
42,25747,55072,89434,32868,16669,55350,6035,8385,9745,1036,3505,9816,8026,0679,4818,5688,3477,5272,0622,047
> Total Stockholder Equity
2,117,251
2,258,106
2,256,431
2,497,027
2,678,860
2,864,984
2,709,234
2,885,679
3,026,049
3,145,835
3,278,804
3,360,751
3,432,887
3,738,127
3,932,509
4,129,903
4,250,376
4,481,854
4,629,920
4,864,043
4,864,0434,629,9204,481,8544,250,3764,129,9033,932,5093,738,1273,432,8873,360,7513,278,8043,145,8353,026,0492,885,6792,709,2342,864,9842,678,8602,497,0272,256,4312,258,1062,117,251
   Common Stock
0
578
579
580
580
582
582
583
583
585
585
586
586
588
0
588
0
0
0
0
000058805885865865855855835835825825805805795780
   Retained Earnings 
2,500,506
2,604,910
2,711,639
2,832,991
2,953,709
3,076,569
2,941,336
3,079,640
3,222,064
3,362,570
3,480,163
3,613,736
3,759,783
3,920,197
4,088,057
4,253,016
4,401,841
4,539,963
4,769,963
4,991,647
4,991,6474,769,9634,539,9634,401,8414,253,0164,088,0573,920,1973,759,7833,613,7363,480,1633,362,5703,222,0643,079,6402,941,3363,076,5692,953,7092,832,9912,711,6392,604,9102,500,506
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 0000-272,5280-270,168-406,128-312,747-224,141-223,095-217,003-193,487-195,973-163,151-240,191-283,982-366,436-246,1180



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue4,685,297
Cost of Revenue-2,029,994
Gross Profit2,655,3032,655,303
 
Operating Income (+$)
Gross Profit2,655,303
Operating Expense-3,301,176
Operating Income1,384,121-645,873
 
Operating Expense (+$)
Research Development307,525
Selling General Administrative917,136
Selling And Marketing Expenses-
Operating Expense3,301,1761,224,661
 
Net Interest Income (+$)
Interest Income-
Interest Expense-45,708
Other Finance Cost-0
Net Interest Income-45,708
 
Pretax Income (+$)
Operating Income1,384,121
Net Interest Income-45,708
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,264,7981,457,736
EBIT - interestExpense = -45,708
1,020,951
1,066,659
Interest Expense45,708
Earnings Before Interest and Taxes (EBIT)-1,310,506
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,264,798
Tax Provision-243,847
Net Income From Continuing Ops1,020,9511,020,951
Net Income1,020,951
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-73,61545,708
 

Technical Analysis of Resmed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Resmed. The general trend of Resmed is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Resmed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Resmed Inc DRC.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 21.80 < 21.80 < 22.80.

The bearish price targets are: 21.26 > 20.88 > 20.88.

Tweet this
Resmed Inc DRC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Resmed Inc DRC. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Resmed Inc DRC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Resmed Inc DRC. The current macd is 0.59174152.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Resmed price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Resmed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Resmed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Resmed Inc DRC Daily Moving Average Convergence/Divergence (MACD) ChartResmed Inc DRC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Resmed Inc DRC. The current adx is 44.25.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Resmed shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Resmed Inc DRC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Resmed Inc DRC. The current sar is 22.73.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Resmed Inc DRC Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Resmed Inc DRC. The current rsi is 51.56. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Resmed Inc DRC Daily Relative Strength Index (RSI) ChartResmed Inc DRC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Resmed Inc DRC. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Resmed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Resmed Inc DRC Daily Stochastic Oscillator ChartResmed Inc DRC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Resmed Inc DRC. The current cci is -35.4440462.

Resmed Inc DRC Daily Commodity Channel Index (CCI) ChartResmed Inc DRC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Resmed Inc DRC. The current cmo is -13.54127399.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Resmed Inc DRC Daily Chande Momentum Oscillator (CMO) ChartResmed Inc DRC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Resmed Inc DRC. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Resmed Inc DRC Daily Williams %R ChartResmed Inc DRC Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Resmed Inc DRC.

Resmed Inc DRC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Resmed Inc DRC. The current atr is 0.32421495.

Resmed Inc DRC Daily Average True Range (ATR) ChartResmed Inc DRC Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Resmed Inc DRC. The current obv is 5,339.

Resmed Inc DRC Daily On-Balance Volume (OBV) ChartResmed Inc DRC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Resmed Inc DRC. The current mfi is 67.23.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Resmed Inc DRC Daily Money Flow Index (MFI) ChartResmed Inc DRC Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Resmed Inc DRC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-06 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-17 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-20 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-28 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-29 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-30 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-07 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-06-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-14 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-17 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-18 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-19 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-24 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-27 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-15 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-24 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-29 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-31 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-12 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-16 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-22 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-26 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-16 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Resmed Inc DRC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Resmed Inc DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.564
Ma 20Greater thanMa 5021.730
Ma 50Greater thanMa 10020.005
Ma 100Greater thanMa 20019.182
OpenGreater thanClose21.400
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Resmed with someone you think should read this too:
  • Are you bullish or bearish on Resmed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Resmed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Resmed Inc DRC

I send you an email if I find something interesting about Resmed Inc DRC.


Comments

How you think about this?

Leave a comment

Stay informed about Resmed Inc DRC.

Receive notifications about Resmed Inc DRC in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.